. 2023 Mar 15;42(2):289-295. doi: 10.5937/jomb0-40379

Table 4. Serum markers of fibrosis damage.

Note: Compared to controls, ^aP< 0.05; compared to diabetes group, ^bP<0.05; compared to mild DN group, ^cP<0.05.

Groups	TGF-β (μg/L)	HA (μg/L)	CIV (μg/L)	PCIII (μg/L)
Controls	5.28±0.8	30.85±4.69	41.29±6.33	23.69±2.69
Diabetes	8.25±0.91^a	42.68±5.24^a	59.14±6.85^a	32.75±3.22^a
Mild DN	12.24±1.36^ab	58.33±6.96^ab	67.32±7.17^ab	44.23±4.16^ab
Moderate-severe DN	15.21±1.98^abc	78.91±9.51^abc	89.53±9.24^abc	55.98±5.96^abc
F	621.003	524.517	280.321	646.206
P	<0.001	<0.001	<0.001	<0.001